Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
125226511 | 12522651 | 1 | I | 2009 | 20160621 | 20160701 | 20160701 | EXP | US-ELI_LILLY_AND_COMPANY-US201606007993 | ELI LILLY AND CO | 0.00 | F | Y | 0.00000 | 20160701 | CN | US | US |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
125226511 | 12522651 | 1 | PS | HUMALOG | INSULIN LISPRO | 1 | Unknown | UNK, PRN | 20563 | INJECTION | |||||||||
125226511 | 12522651 | 2 | SS | HUMALOG | INSULIN LISPRO | 1 | Unknown | UNK, PRN | C522514D | 20563 | INJECTION | ||||||||
125226511 | 12522651 | 3 | SS | HUMALOG | INSULIN LISPRO | 1 | Unknown | UNK, PRN | U | U | 0 | INJECTION | |||||||
125226511 | 12522651 | 4 | C | LANTUS | INSULIN GLARGINE | 1 | U | 0 | |||||||||||
125226511 | 12522651 | 5 | C | NIACIN. | NIACIN | 1 | U | 0 | |||||||||||
125226511 | 12522651 | 6 | C | LISINOPRIL. | LISINOPRIL | 1 | U | 0 | |||||||||||
125226511 | 12522651 | 7 | C | FENOFIBRATE. | FENOFIBRATE | 1 | U | 0 | |||||||||||
125226511 | 12522651 | 8 | C | ASPIRIN /00002701/ | ASPIRIN | 1 | U | 0 | |||||||||||
125226511 | 12522651 | 9 | C | PLAVIX | CLOPIDOGREL BISULFATE | 1 | U | 0 | |||||||||||
125226511 | 12522651 | 10 | C | ACETIC ACID POTASSIUM | 2 | U | 0 |
Indications of drugs used
Event ID | CASEID | INDI DRUG SEQ | INDI PT |
---|---|---|---|
125226511 | 12522651 | 1 | Diabetes mellitus |
125226511 | 12522651 | 3 | Diabetes mellitus |
125226511 | 12522651 | 4 | Product used for unknown indication |
125226511 | 12522651 | 5 | Blood cholesterol |
125226511 | 12522651 | 6 | Cardiac disorder |
125226511 | 12522651 | 7 | Product used for unknown indication |
125226511 | 12522651 | 8 | Product used for unknown indication |
125226511 | 12522651 | 9 | Product used for unknown indication |
125226511 | 12522651 | 10 | Product used for unknown indication |
Outcome of event
Event ID | CASEID | OUTC COD |
---|---|---|
125226511 | 12522651 | OT |
125226511 | 12522651 | HO |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
125226511 | 12522651 | Blood glucose decreased | |
125226511 | 12522651 | Coma | |
125226511 | 12522651 | Feeling abnormal | |
125226511 | 12522651 | Heart rate decreased | |
125226511 | 12522651 | Loss of consciousness | |
125226511 | 12522651 | Seizure |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
---|---|---|---|---|---|---|
125226511 | 12522651 | 1 | 2015 | 0 | ||
125226511 | 12522651 | 2 | 2015 | 0 | ||
125226511 | 12522651 | 3 | 2008 | 2015 | 0 |